Assesment and Comparison of Osteoporosis Risk Factors After Stroke
Recruiting · NCT07228611 · Observational (researchers observe without assigning treatment) · Lead sponsor: Ankara Etlik City Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Bone Mineral Density
What this trial is about
The aim of this study is to evaluate the effect of these factors and stroke itself on osteoporosis developing after stroke. Thus, the expected benefit of the study is to contribute to the identification and determination of the need for treatment in high-risk patients through further studies. There are no expected risks from the study.
Who can take part
Age range
55 Years to 85 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Followed by ischemic or hemorrhagic stroke
- Between 1 week and 6 months or \>1 year has passed since the date of the event
- Being between 55 and 85 years of age
Exclusion criteria
- The patient has additional neurological conditions besides stroke
- The patient has a psychiatric condition
- History of recurrent stroke
- BMD scan performed within the last year for stroke patients
- Having received osteoporosis treatment before or after the stroke
- The patient having a fragility fracture before the stroke
- The patient having a hip fracture or hip prosthesis
- The patient having an additional condition that affects physical function before the stroke (amputation, severe fracture)
- The patient has an additional disease or medication use that could cause secondary osteoporosis
- The patient's stroke did not cause physical function loss
Where it is running
1 location listed.
- Ankara Etlik City Hospital - Ankara, Yenimahalle, Turkey (Türkiye)